Baltimore News Journal – Lifestyle
Author:
ATISAMA THERAPEUTICS
Atisama Therapeutics Advances RB042 into Multiple Ascending Dose cohorts of Phase 1 Trial and Appoints Bernard Coulie as Chair of the Board
May 15, 2026